Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus

NCT05969496 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Renal Cancer
Kidney Cancer
Renal Cell Carcinoma
Inferior Vena Cava Thrombosis

Interventions

DRUG: Axitinib
DRUG: Pembrolizumab

Sponsor

University of Colorado, Denver

Collaborators

[object Object]